KindlyMD Faces Nasdaq Delisting Risk After Prolonged Share Price Decline

The assessment is "likely_true" with high confidence because all four provided sources are unanimous in their reporting. They consistently confirm that KindlyMD has received a formal delisting warning from the Nasdaq stock exchange. The reason cited across all reports is the company's failure to meet the minimum bid price requirement, which is typically shares trading below $1.00 for 30 consecutive business days. The language used in the sources, such as "delisting warning," "faces Nasdaq delisting warning," and "delisting risk," directly supports the statement's claim that the company is "at risk of being delisted." Furthermore, multiple sources corroborate the detail that KindlyMD has a 180-day compliance period to rectify the situation, which perfectly encapsulates the concept of being "at risk" rather than having already been delisted. There are no contradictions in the evidence provided. The high degree of consistency across multiple independent reports, even with varying authority levels, provides a strong basis for the conclusion.